Dr. Michael Rodriguez

Associate Professor of Hematology

MD Anderson Cancer Center

Houston, Texas, United States

AML Precision Medicine Clinical Trials

Biography

Dr. Rodriguez is a leading expert in precision medicine for acute myeloid leukemia. His research focuses on identifying genetic markers that predict treatment response and developing personalized treatment strategies. He has led numerous clinical trials and published extensively on AML genetics and treatment outcomes. His work has contributed to the development of personalized treatment protocols now used worldwide.

Education

  • MD Baylor College of Medicine (2012)
  • PhD in Molecular Biology Rice University (2012)

Awards & Honors

  • • ASCO Merit Award
  • • NIH Career Development Award